Current Insights on Antifungal Therapy: Novel Nanotechnology Approaches for Drug Delivery Systems and New Drugs from Natural Sources

Overview

Journal Pharmaceuticals (Basel)

Publisher MDPI

Specialty Chemistry

Date 2020 Sep 18

PMID 32942693

Citations 42

Authors

Filipa Sousa

Domingos Ferreira

Salette Reis

Paulo Costa

Affiliations

Soon will be listed here.

Abstract

The high incidence of fungal infections has become a worrisome public health issue, having been aggravated by an increase in host predisposition factors. Despite all the drugs available on the market to treat these diseases, their efficiency is questionable, and their side effects cannot be neglected. Bearing that in mind, it is of upmost importance to synthetize new and innovative carriers for these medicines not only to fight emerging fungal infections but also to avert the increase in drug-resistant strains. Although it has revealed to be a difficult job, new nano-based drug delivery systems and even new cellular targets and compounds with antifungal potential are now being investigated. This article will provide a summary of the state-of-the-art strategies that have been studied in order to improve antifungal therapy and reduce adverse effects of conventional drugs. The bidirectional relationship between Mycology and Nanotechnology will be also explained. Furthermore, the article will focus on new compounds from the marine environment which have a proven antifungal potential and may act as platforms to discover drug-like characteristics, highlighting the challenges of the translation of these natural compounds into the clinical pipeline.

Citing Articles

Novel Strategies for Preventing Fungal Infections-Outline.

Agbadamashi D, Price C Pathogens. 2025; 14(2).

PMID: 40005503 PMC: 11858109. DOI: 10.3390/pathogens14020126.

A mechanistic overview on green assisted formulation of nanocomposites and their multifunctional role in biomedical applications.

Mahnoor , Malik K, Kazmi A, Sultana T, Raja N, Bibi Y Heliyon. 2025; 11(3):e41654.

PMID: 39916856 PMC: 11800088. DOI: 10.1016/j.heliyon.2025.e41654.

Synergistic Antifungal Activity of Terbinafine in Combination with Light-Activated Gelatin-Silver Nanoparticles Against Strains.

Ullah A, Ali F, Ullah F, Sadozai S, Khan S, Hussain S Pharmaceutics. 2025; 17(1).

PMID: 39861772 PMC: 11768782. DOI: 10.3390/pharmaceutics17010125.

Non-Viral Delivery Systems to Transport Nucleic Acids for Inherited Retinal Disorders.

Jony M, Joshi A, Dash A, Shukla S Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861150 PMC: 11768406. DOI: 10.3390/ph18010087.

Prioritizing oral bioavailability in drug development strategies.

Xie L, Hong Y, Hu Y, Li H, Lou J, Zhou X Future Med Chem. 2024; 17(2):149-151.

PMID: 39723437 PMC: 11749343. DOI: 10.1080/17568919.2024.2444871.

References

Verma S, Utreja P . Vesicular nanocarrier based treatment of skin fungal infections: Potential and emerging trends in nanoscale pharmacotherapy. Asian J Pharm Sci. 2020; 14(2):117-129. PMC: 7042486. DOI: 10.1016/j.ajps.2018.05.007. View

Beloqui A, Solinis M, Rodriguez-Gascon A, Almeida A, Preat V . Nanostructured lipid carriers: Promising drug delivery systems for future clinics. Nanomedicine. 2015; 12(1):143-61. DOI: 10.1016/j.nano.2015.09.004. View

Zazo H, Colino C, Lanao J . Current applications of nanoparticles in infectious diseases. J Control Release. 2016; 224:86-102. DOI: 10.1016/j.jconrel.2016.01.008. View

Ing L, Mohamad Zin N, Sarwar A, Katas H . Antifungal activity of chitosan nanoparticles and correlation with their physical properties. Int J Biomater. 2012; 2012:632698. PMC: 3399401. DOI: 10.1155/2012/632698. View

Kumar L, Verma S, Bhardwaj A, Vaidya S, Vaidya B . Eradication of superficial fungal infections by conventional and novel approaches: a comprehensive review. Artif Cells Nanomed Biotechnol. 2013; 42(1):32-46. DOI: 10.3109/21691401.2013.769446. View

Newman D, Cragg G . Natural Products as Sources of New Drugs from 1981 to 2014. J Nat Prod. 2016; 79(3):629-61. DOI: 10.1021/acs.jnatprod.5b01055. View

Kumar R, Sinha V . Preparation and optimization of voriconazole microemulsion for ocular delivery. Colloids Surf B Biointerfaces. 2014; 117:82-8. DOI: 10.1016/j.colsurfb.2014.02.007. View

Faisal W, Soliman G, Hamdan A . Enhanced skin deposition and delivery of voriconazole using ethosomal preparations. J Liposome Res. 2016; 28(1):14-21. DOI: 10.1080/08982104.2016.1239636. View

Souto E, Wissing S, Barbosa C, Muller R . Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm. 2004; 278(1):71-7. DOI: 10.1016/j.ijpharm.2004.02.032. View

10.

Pandurangan D, Bodagala P, Palanirajan V, Govindaraj S . Formulation and evaluation of voriconazole ophthalmic solid lipid nanoparticles in situ gel. Int J Pharm Investig. 2016; 6(1):56-62. PMC: 4787063. DOI: 10.4103/2230-973X.176488. View

11.

Pelgrift R, Friedman A . Nanotechnology as a therapeutic tool to combat microbial resistance. Adv Drug Deliv Rev. 2013; 65(13-14):1803-15. DOI: 10.1016/j.addr.2013.07.011. View

12.

Saldanha C, Garcia M, Iocca D, Rebelo L, Souza A, Bocca A . Antifungal Activity of Amphotericin B Conjugated to Nanosized Magnetite in the Treatment of Paracoccidioidomycosis. PLoS Negl Trop Dis. 2016; 10(6):e0004754. PMC: 4909273. DOI: 10.1371/journal.pntd.0004754. View

13.

Sherje A, Jadhav M, Dravyakar B, Kadam D . Dendrimers: A versatile nanocarrier for drug delivery and targeting. Int J Pharm. 2018; 548(1):707-720. DOI: 10.1016/j.ijpharm.2018.07.030. View

14.

Sun Q, Li J, Le T . Zinc Oxide Nanoparticle as a Novel Class of Antifungal Agents: Current Advances and Future Perspectives. J Agric Food Chem. 2018; 66(43):11209-11220. DOI: 10.1021/acs.jafc.8b03210. View

15.

Srinivasan A, Lopez-Ribot J, Ramasubramanian A . Overcoming antifungal resistance. Drug Discov Today Technol. 2014; 11:65-71. PMC: 4031462. DOI: 10.1016/j.ddtec.2014.02.005. View

16.

Qushawy M, Nasr A, Abd-Alhaseeb M, Swidan S . Design, Optimization and Characterization of a Transfersomal Gel Using Miconazole Nitrate for the Treatment of Candida Skin Infections. Pharmaceutics. 2018; 10(1). PMC: 5874839. DOI: 10.3390/pharmaceutics10010026. View

17.

Zheng W, Fang X, Wang L, Zhang Y . Preparation and quality assessment of itraconazole transfersomes. Int J Pharm. 2012; 436(1-2):291-8. DOI: 10.1016/j.ijpharm.2012.07.003. View

18.

Jung S, Lim D, Jung S, Lee J, Jeong K, Seong H . Amphotericin B-entrapping lipid nanoparticles and their in vitro and in vivo characteristics. Eur J Pharm Sci. 2009; 37(3-4):313-20. DOI: 10.1016/j.ejps.2009.02.021. View

19.

Puglia C, Blasi P, Ostacolo C, Sommella E, Bucolo C, Platania C . Innovative Nanoparticles Enhance -Palmitoylethanolamide Intraocular Delivery. Front Pharmacol. 2018; 9:285. PMC: 5882782. DOI: 10.3389/fphar.2018.00285. View

20.

Verma P, Pathak K . Nanosized ethanolic vesicles loaded with econazole nitrate for the treatment of deep fungal infections through topical gel formulation. Nanomedicine. 2011; 8(4):489-96. DOI: 10.1016/j.nano.2011.07.004. View